• gmp-verlag.de
  • GMP MANUAL Login
  • Shopping cart
Stay informed!

If you’d like to be regularly informed of the latest developments at Good Manufacturing Practices


>>> simply register for our free GMP newsletter LOGFILE


TOP 5 GMP Downloads

1. GDP Audit Checklist
for the Storage and Transport of Pharmaceuticals


2. Quality Agreement
Standard draft to adapt and extend


3. Premises
Official requirements | material flow | room classes | and much more...


4. GMP Audit Checklist
for Pharmaceutical and API Manufacturers


5. Documenting Process Validation
A Drugmaker‘s Guide – step-by-step manual based on real-world examination experience


Your benefits:

> no shipping costs
> no waiting period: if you choose payment by credit card you will receive an email with the download information immediately after payment.


>>> Click here to find more Downloads!

News about GMP/cGMP


The European Medicines Agency (EMA) and the US FDA have published a second joint Q&A document which provides guidance on the quality by design concept, a risk based approach to pharmaceutical development and manufacturing. It involves designing and developing pharmaceutical formulations and manufacturing processes to help ensure product quality; these concepts are described in the international guidelines ICH Q8, Q9, Q10 and Q11.


The US Food and Drug Administration (FDA) has proposed a new regulation that would require pharmaceutical manufacturers to provide the agency with advance warning of impending drug shortages.


MHRA has developed a new guidance document for Manufacturing Specials (MS) to ensure consistency during routine Good Manufacturing Practice (GMP) inspections and to ensure MS licence holders are aware of the authorities’ expectations in this complicated area.


The TGA has announced the launch of the Medical Device Single Audit Program (MDSAP) from January 2014, together with Brazil's ANVISA, Health Canada, and the US Food and Drug Administration FDA, to develop a global approach to auditing and monitoring the safe manufacturing of medical devices.


In the past nine months, the US regulator has expanded its inspection team in India from 12 to 19, and opened two more offices in Hyderabad and Mumbai, in addition to its first office in New Delhi. With 135 FDA-approved manufacturing units in India and rising compliance problems this comes as no surprise.


The European Medicines Agency (EMA) has announced details of its new organisational structure with the intention to better support its health mission and its role as part of the European medicines regulatory system.


On October 2, 2013, the EMA’s Management Board agreed to publish the agendas and minutes of all its scientific committees. This is part of the EMA’s approach to increasing transparency and opening up its operations.


The Japanese Ministry of Health (MHLW) and the PMDA have started entering information on good manufacturing practice (GMP) compliance related to Japanese manufacturers, upon the manufacturer's request, into the EudraGMDP database. This is the first time that information from a non-European regulator has started to be added to EudraGMDP. The initiative is expected to speed up regulatory processes and save time for importers, manufacturers and regulatory authorities.

Page 8/50    4   5   6   7   8   9   10   11   12   13